CellaVision AB - Interim report for the period January 1 - September
30, 2009
(Thomson Reuters ONE) - Successful launch of CellaVision® DM1200 and a solid earnings trend* Net sales increased by 12% to SEK 69.6 million (62.1), of which the third quarter accounted for SEK 27.0 million (20.8).* The operating profit for the period was SEK 7.3 million (6.3), and for the third quarter SEK 5.5 million (3.6).* Earnings per share for the period amounted to SEK 0.28 (0.25), and for the third quarter SEK 0.22 (0.14).* Cash and cash equivalents amounted to SEK 11.9 million (11.3) by the end of the period.* The new analyzer CellaVision® DM1200 became commercially available in Europe and Canada and was successfully introduced on the market. The first substantial order was taken in Europe. CellaVision in summary (MSEK) Q3 2009 Q3 2008 Jan-Sep 2009 Jan-Sep Full year 2008 2008 Net sales 27.0 20.8 69.6 62.1 100.4 Gross profit 20.1 16.6 51.0 42.4 63.5 Operating 5.5 3.6 7.3 6.3 13.4result Net result 5.4 3.4 6.8 6.0 13.1 Cash flow 2.6 -5.6 -7.7 -5.0 3.3CEO's comment"Our new product CellaVision DM1200 is now commercially available inboth Europe and Canada which will be beneficial for sales," saysYvonne Mårtensson, CEO of CellaVision. "We got the first substantialorder from our distributor Sysmex Europe. The order comprised closeto twenty analyzers, which indicates that adapting our product to theneeds of medium-sized hospitals was strategically correct.""We show solid increase in terms of both revenue and results duringthe third quarter despite the global financial crisis, and wecontinue to show a strong gross margin.""During the quarter our own sales organizations have taken ordersfrom important customers in the USA, Canada, Japan, as well as theNordic region, and we continue to work hard to strengthen ourposition in each of those markets."Yvonne MårtenssonCEO CellaVision ABFor further information, please contact:Yvonne Mårtensson, CEO. Phone: +46 708 33 77 82, e-mail:yvonne.martensson(at)cellavision.comJohan Wennerholm, CFO. Phone: +46 708 33 81 68, e-mail:johan.wennerholm(at)cellavision.comhttp://hugin.info/132164/R/1349523/325262.pdfThis announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.
Datum: 23.10.2009 - 08:32 Uhr
Sprache: Deutsch
News-ID 7332
Anzahl Zeichen: 0
contact information:
Town:
London
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 250 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"CellaVision AB - Interim report for the period January 1 - September
30, 2009"
steht unter der journalistisch-redaktionellen Verantwortung von
CellaVision AB (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
